Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0393754 (
HSA
)
2,996
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Skeletal, reticuloendothelial and renal images were obtained on a patient with osteopetrosis using Tc-99m
MDP
, Tc-99m
HSA
millimicrospheres and Tc-99m DTPA respectively. The bone scan showed increased uptake in multiple fracture sites, in the frontal bone, and in the splayed metaphyses of long bones while the remainder of the skeleton appeared normal. Reticuloendothelial images demonstrated an absence of bone marrow activity, hepatosplenomegaly and a site of extramedullary hematopoiesis. A renogram demonstrated a left kidney displaced and distorted by the massive splenomegaly.
...
PMID:Scintigraphy in a patient with complicated osteopetrosis. 265 38
The
HSA
-binding of 99mTc incubated as 99mTc(113Sn)-
MDP
depends in vitro on the presence of competing anions normally present in plasma and on the
MDP
and Tc concentration, but is independent of the Sn concentration. The
HSA
-binding of 113Sn depends on the
MDP
and Sn concentration; not on the Tc concentration. 99mTc(Sn)-
MDP
binds to
HSA
as a unit. The binding of 99mTc(Sn)-
MDP
to plasma proteins in vivo is much lower as calculated from in vitro experiments because of competition between 99mTc(Sn)-
MDP
and endogenous anions for the same binding-sites.
...
PMID:Binding of 99mTc(113Sn)-MDP to human serum albumin. The influence of various technetium, tin, and MDP concentrations. 359 13
Aneurysmal bone cyst is rarely found in the mandible, and roentgenographic diagnosis of this condition is not easily made. In this report, the diagnostic value of bone scintigraphy and radionuclide angiography and CT imaging in two cases of aneurysmal bone cyst of the mandible are discussed. Bone scintigraphy with Tc-99m
MDP
demonstrated ring-like or doughnut-pattern accumulation of radioactivity, which corresponded to the expansile character of the bony lesion. The accumulation of radioactivity was intensive in the peripheral region despite the fact that the lesion was benign. Furthermore, the central rarefaction showed that the lesion was cystic. Radionuclide angiography with Tc-99m
HSA
, including blood pool scan, did not detect radioactive concentration. Thus bone scintigraphy and radionuclide angiography were found to be essential in the differential diagnosis of aneurysmal bone cyst from other forms of tumor, especially hypervascularized tumor and central hemangioma of the mandible.
...
PMID:Diagnosis of aneurysmal bone cyst of the mandible. A report of two cases with emphasis on scintigraphic approaches. 407 71
Nuclear cardiovascular studies are being introduced in almost every Nuclear Medicine Department. The number of studies performed per week is increasing very rapidly. The physical characteristics including the specific gamma ray constant for radionuclides used in cardiovascular studies are listed. The radiation dose estimates to different organs of a patient administered with 201Tl and 99mTc radiopharmaceuticals are shown. The radiation levels measured around patients administered with 201Tl chloride, 99mTc
HSA
(human serum albumin), and 99mTc-
MDP
(methylene diphosphonate) are within the permissible limits. Radiation doses to different organs from nuclear cardiovascular studies are less than those associated with fluoroscopy, particularly cardiac catheterization. However, the gonadal doses received from cardiac catheterization and angiocardiography are considerably lower than nuclear cardiovascular studies.
...
PMID:Radiation exposure in nuclear cardiovascular studies. 706 77
Tc-99m polyclonal immunoglobulin-G has been shown to be a successful agent in the depiction of active inflammation in rheumatoid arthritis (RA). The objective of this study was to compare the uptake behaviors of Tc-99m HIG and Tc-99m
MDP
in RA and variants of rheumatoid arthritis (VRA). Seventeen patients with RA and 8 patients with VRA presenting with active inflammation were included in this study. Ten subjects with well-diagnosed degenerative joint disease constituted the control group. All joints in patients were also imaged with Tc-99m
HSA
to evaluate the vascularization status of the joints. Tc-99m HIG and
HSA
scans were obtained at 2, 4 and 24 hours after the injection of 555 MBq Tc-99m HIG and 296 MBq Tc-99m
HSA
. Conventional bone scans were performed 4 hours after the injection of 740 MBq Tc-99m
MDP
. Target-to-background (T/B) ratios were obtained exclusively over the joint regions. Tc-99m HIG T/B ratios of the active joints in RA were significantly higher than those of the non-active joints and the control group (p < 0.05). Tc-99m HIG T/B ratios in active joints showed a progressive increase between 2 and 24 hour images (p < 0.05). In contrast, Tc-99m
HSA
T/B ratios decreased in all active joints significantly (p < 0.05) except the ankle joint region (p > 0.05). The T/B ratios in Tc-99m
MDP
bone scans were higher in all active joints than in non-active RA joints and joints of controls but significantly differences were only detected in wrist and elbow joints. All clinically active joints in VRA patients accumulated Tc-99m HIG and
HSA
, and showed increased Tc-99m
MDP
uptake. These joints had a very similar Tc-99m HIG retention pattern to the RA joints. The detection rate of active joint inflammation with Tc-99m HIG was much higher than that with Tc-99m
MDP
. The increasing Tc-99m HIG uptake ratio between 2 and 24 hours in contrast to Tc-99m
HSA
indicates the presence of other binding mechanisms besides increased vascularity in RA.
...
PMID:Comparison of Tc-99m MDP, Tc-99m HSA and Tc-99m HIG uptake in rheumatoid arthritis and its variants. 1065 72
We report a study of the renal and whole-blood kinetics of (18)F-fluoride and (99m)Tc-methylene diphosphonate ((99m)Tc-
MDP
) and their effect on the evaluation of the skeletal kinetics of the two bone tracers. Data were obtained during an investigation of postmenopausal women taking hormone replacement therapy who were compared with untreated, age-matched controls. After intravenous injection of 18F-fluoride (1 MBq), (99m)Tc-
MDP
(1 MBq), (51)Cr-ethylenediaminetetraacetic acid (51Cr-EDTA) (3 MBq) and (125)I-human serum albumin ((125)I-
HSA
) (0.25 MBq), multiple blood samples and urine collections were taken between 0 and 4 h after injection. (51)Cr-EDTA data were used to evaluate the glomerular filtration rate (GFR) and the completeness of each timed urine collection. (125)I-
HSA
data were used to evaluate the plasma volume and the red cell uptake of the other three tracers. At 4 h, the cumulative urine excretions (and standard deviations, SDs) were: (99m)Tc-
MDP
, 58.2% (4.8%); (18)F-fluoride, 36.1% (5.7%); (51)Cr-EDTA, 81.5% (4.5%). Plots of the renal clearance of (18)F-fluoride against urine volume showed that urine flow rates greater than 5 ml.min-1 were necessary to ensure a constant renal clearance of (18)F and hence stable conditions for the evaluation of bone tracer kinetics. In contrast, a low urine flow rate had no effect on the renal kinetics of (99m)Tc-
MDP
. For
MDP
, the evaluation of skeletal kinetics requires data on protein binding so that calculations can be performed for free
MDP
. In the present study, protein binding of
MDP
was evaluated from the ratio of total (99m)Tc-
MDP
renal clearance to GFR based on the principle that free (99m)Tc-
MDP
is a GFR tracer. Between 0 and 4 h after injection, the fractional protein binding of
MDP
increased linearly with time, changing from 21+/-5% immediately after injection to 58+/-5% at 4 h. Although red cell uptake of (99m)Tc-
MDP
was negligible, for (18)F-fluoride around 30% of circulating tracer was transported in red cells. In view of the data showing the rapid transport of (18)F-fluoride across the red cell membrane, bone kinetic data for (18)F are more accurately reported as whole-blood clearance rather than plasma clearance.
...
PMID:Quantitative studies of bone using (18)F-fluoride and (99m)Tc-methylene diphosphonate: evaluation of renal and whole-blood kinetics. 1150 14
The authors describe a patient with protein-losing enteropathy in whom abnormal intestinal accumulation of tracer occurred during Tc-99m human serum albumin scintigraphy. Abnormal leakage of the radiotracer was observed in the left upper abdomen and was confirmed by Tc-99m
MDP
scintigraphy. Both Tc-99m
HSA
scintigraphy and Tc-99m
MDP
scintigraphy are useful in the detection of protein-losing enteropathy.
...
PMID:Protein-losing enteropathy detected on Tc-99m HSA and Tc-99m MDP scintigraphy. 1204 36